SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-005245
Filing Date
2004-11-09
Accepted
2004-11-09 16:13:17
Documents
4
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b51855aie10vq.htm 10-Q 342587
2 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b51855aiexv31w1.txt EX-31.1 3483
3 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b51855aiexv31w2.txt EX-31.2 3426
4 EX-32.1 SETION 906 CERTIFICATIONS OF C.E.O & C.F.O. b51855aiexv32w1.txt EX-32.1 1841
  Complete submission text file 0000950135-04-005245.txt   353331
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 041129826
SIC: 2836 Biological Products, (No Diagnostic Substances)